Oncology & Cancer

Improving the conversion success rate of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) presents significant challenges due to its high incidence and mortality rates, particularly in China where most patients are diagnosed at intermediate or advanced stages. This limits the applicability ...

Medications

Epstein-Barr virus associated tumors and drug repurposing

A new study published in OMICS: A Journal of Integrative Biology identified differentially expressed host and viral microRNAs (miRNAs) in six Epstein-Barr virus (EBV) associated tumors. The study reports several drug candidates ...

page 3 from 3